Fragmented systems make coordinated care difficult for people with intellectual and developmental disabilities. A new interoperability model using the eLTSS standard connects healthcare providers and community organizations to share person-centered service plans and improve outcomes for vulnerable populations.
A new human factors study reveals the hidden complexity behind sterile processing. Research from the Medical University of South Carolina shows how sterile processing, operating rooms, and courier networks function as one interconnected system. Understanding “work as done” rather than “work as imagined” may be key to improving surgical safety and supporting frontline staff.
Over 50% of surgeries experience delays that increase the risk of infection. Tampa General's ambient AI reduced OR turnover times by 12%, preventing dangerous complications and enabling more than 832 additional cases annually. Real-time data transforms surgical safety and efficiency.
Dental assistants manage sterilization, infection control, and patient education—yet most states require zero formal training. They earn the lowest wages in dental offices. Meet Sherrie Busby's 42-year mission to secure standardized credentialing and fair recognition. (Audio podcast)
Dental assistants help bridge communication gaps between dentists and patients. Experts say patient education, follow-up conversations, and modern diagnostic tools are essential for helping individuals understand treatment recommendations and make informed oral health decisions.
Dental Assistants Recognition Week spotlights the critical role dental assistants play in infection prevention, patient safety, and instrument sterilization. From PPE adherence to surface disinfection and patient education, these professionals manage complex clinical and administrative tasks that protect both patients and dental teams in high-risk aerosol-generating environments. (Entire interview)
Hospital-onset bacteremia is common in burn patients—and often tied to burn severity and surgical wound care, not lapses in quality. New data suggest that HOB may be a poor standalone quality metric for burn centers, raising questions about the fairness of benchmarking in value-based care.
When sterile instruments look perfect but hidden soil remains, patient safety is at risk. In this in-depth ICT article, Marjorie Wall, EDBA, CRCST, CIS, CHL, CSSBB, explains why ultrasonic cleaning is not just equipment, but a critical quality system, and how failures in cavitation, lumen flushing, or water quality can quietly undermine infection prevention in the operating room and sterile processing department.
A multicenter randomized trial of 276 patients with sepsis found that precision immunotherapy targeting immune dysfunction improved organ failure scores by day 9 compared with placebo. Although mortality differences were not statistically significant, the results suggest that biomarker-guided treatment strategies could help personalize sepsis care and improve clinical outcomes.
Long-acting injectables have transformed HIV management, but viral suppression alone is not enough. Researchers are advancing mRNA vaccines, broadly neutralizing antibodies, latency-reversing agents, pediatric immune strategies, and gene editing to eliminate reservoirs and achieve remission. Here’s how next-generation HIV therapeutics aim to move beyond lifelong ART.
As her 2025 APIC presidency concludes, Carol McLay, DrPH, MPH, RN, CIC, FAPIC, FSHEA, discusses public health funding cuts, science advocacy, global partnerships, workforce development, and why infection preventionists must speak up. In this exclusive ICT interview, she shares lessons from a tumultuous year and her vision for strengthening the infection prevention profession worldwide.
As her 2025 APIC presidency concludes, Carol McLay, DrPH, MPH, RN, CIC, FAPIC, FSHEA, discusses public health funding cuts, science advocacy, global partnerships, workforce development, and why infection preventionists must speak up. In this exclusive ICT interview, she shares lessons from a tumultuous year and her vision for strengthening the infection prevention profession worldwide.
Before a disinfectant reaches a hospital unit, it undergoes rigorous laboratory testing, formulation science, and regulatory validation. In this ICT Q&A, Candice Taylor, MA, explains how R&D bridges lab efficacy with real-world health care workflow, antimicrobial resistance concerns, and the evolving future of infection prevention technology.
A national survey of infection preventionists reveals deep concerns about staffing shortages, lack of leadership support, limited authority, and outdated surveillance systems. IP professionals warn that without structural investment, modernization, and executive recognition of their operational value, patient safety, regulatory compliance, and hospital financial stability remain at risk.
Infection prevention professionals are weighing in on the CDC’s updated vaccine schedule. An ICT survey reveals mixed familiarity, rising patient questions, and a strong call for clearer guidance and communication tools. Here’s what IPC leaders say about implementation, confidence, and the real-world impact of vaccine policy changes.
For Rare Disease Day and Week, ICT presents: Rare autoimmune diseases affect millions worldwide, yet vaccine guidance for these patients remains complex. Understanding disease mechanisms, immunosuppression, and vaccine modalities is critical to reducing infection risk. This article explores practical strategies to guide safe, individualized vaccine decisions in rare autoimmune conditions and protect vulnerable populations.
Dental implant infection prevention starts in the operatory and continues at home. Anjali A. Rajpal, DMD, explains how sterilization protocols, early healing care, warning signs of infection, and long-term hygiene habits protect implant success. Learn what patients must do in the first 72 hours and beyond to reduce risk.
Detox is a short but high-risk window for infection. Disrupted sleep, shared spaces, and intensive medication workflows raise exposure pressure. Leading detox programs in San Diego reduce risk with structured intake screening, disciplined medication handling, time-based cleaning, zoning for symptoms, and practical discharge planning that keeps infections from following patients home.
Antimicrobial resistance (AMR) is accelerating worldwide, with MRSA, carbapenem-resistant Enterobacteriaceae, and drug-resistant gonorrhea threatening modern medicine. As antibiotic development lags, AI-driven discovery, soil-derived compounds like teixobactin, and phage therapy offer renewed hope.
At FDA Rare Disease Day 2026, leaders highlighted new regulatory pathways, faster review programs, and patient-centered innovations accelerating treatments for rare diseases, including NF1 and pediatric cancers. From the Plausible Mechanism Framework to expanded real-world evidence use, the message was clear: Urgency, flexibility, and patient voice are driving rare disease drug development forward.
When operating room delays and tray errors threatened efficiency, leaders at New York Presbyterian built a collaborative bridge with central sterile processing. Through shared metrics, workflow exchanges, and improved communication, first-case-on-time starts climbed from the 50 to nearly 90%.
Cepheid has been selected by the CDC as a national collaborator to accelerate rapid diagnostic development during public health emergencies. With early access to outbreak samples and genomic data, the company aims to shorten response timelines and strengthen U.S. pandemic preparedness through scalable, high accuracy PCR testing solutions.
As debate over COVID-19 origins continues, critics warn that reductions in NIH and CDC biodefense efforts could weaken US pandemic preparedness. From halted CDC databases to shifting NIH priorities, experts question whether scaling back federal response capacity leaves the nation vulnerable to future biological threats and emerging infectious diseases.
At CROI 2026 in Denver, ViiV Healthcare unveiled new data on ultralong-acting HIV treatments, including first-in-human results for third-generation integrase inhibitor VH184 and early capsid inhibitor data. Updated prevention and real-world findings highlight progress toward 4-month dosing and expanded options across adult and pediatric populations.
